Oral medicament for treating cerebral infarction and relieving limb spasm

Abstract

The invention relates to an oral medicament for treating cerebral infarction and relieving limb spasm, and the oral medicament is prepared from the following traditional Chinese medicine active ingredients in parts by weight: 12-40 parts of membranous milkvetch root, 12-40 parts of pachyrhizua angulatus, 10-25 parts of red paeony root, 10-25 parts of szechuan lovage rhizome, 10-20 parts of peach seed, 10-25 parts of suberect spatholobus stem, 10-25 parts of common clubmoss herb, 10-25 parts of glandularstalk st.paulswort herb, 6-20 parts of twotooth achyranthes root and 3-10 parts of earthworm. Efficacy tests prove that the medicament can obviously inhibit the in-vivo blood vessel thrombosis of an animal, reduce the weight of in-vivo arterial and venous thrombus, inhibit the thrombosis and alleviate the clinical symptoms caused by the thrombus; and the medicament further has certain effect of improving coagulation function of rats, and can reduce the platelet aggregation rate, prolong the coagulation time, the PT (prothrombin time) and the APTT (activated partial thromboplastin time), have an obvious effect of improving blood rheology indicators, and can be used for significantly reducing blood viscosity of a rat blood stasis model caused by polymer dextran, improving the blood circulation, and avoiding the potential risk of the thrombosis.

Description

technical field [0001] The invention belongs to the technical field of medical preparations containing raw materials or their reaction products with unknown structures, and specifically relates to materials derived from plants. Background technique [0002] Stroke, also known as stroke and cerebrovascular accident, usually refers to a group of acute diseases including cerebral hemorrhage, cerebral infarction and subarachnoid hemorrhage. Cerebrovascular clinical events with signs of functional loss are common and frequently-occurring diseases of middle-aged and elderly people. They are one of the three diseases with the highest human mortality rate. The most disabling disease causes great suffering to human beings and serious harm to families and society. Moreover, as people's dietary structure changes and the pace of life accelerates, the incidence of stroke increases year by year and tends to become younger. 4.6 million people die from stroke every year in the world, and ...

AI Technical Summary

Problems solved by technology

[0003] The currently marketed medicines for the treatment of cerebral infarction can be divided into two categories. One is local standard old medicines listed in the early stage, such as Huatuo Zaizao Pills, Zhongfeng Huichun Pills, etc. These products have not undergone strict randomized and double-blind trials. , controlled, and multi-center clinical trials, the curative effect needs to be further confirmed, and the indications are wide, and the curative effect is not concentrated; one is Chinese patent medicines approved in recent years, such as Nao'an Capsules, Naoxintong Capsules, etc. , but they are all large and comprehensive products, the curative effect is not outstanding, and the pertinence is not strong

Images